Figure 1.

QRT-PCR Analysis of bone morphogenetic protein (BMP) antagonist expression across gestation in the human fetal ovary. Expression levels of each gene are given, normalised to the level of RPL32 in each sample. Ovary gestations are grouped to represent different stages in development as described in the main text. Results for individual samples (n = 5–6 for each stage) are presented along with median values. Changes between stages were analysed by the Kruskal–Wallis Test with Dunn's multiple comparisons and different letters above groups represent statistically significant differences (p ≤ 0.05, or less as indicated in the main text).